See also this year's filing and all EDGAR filings for this company.
PDF Report 0001069308_2012_Acer_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'NetIncome', 'value': -109611620, 'size_variable': 'Assets', 'size_value': 4146070, 'ratio': 26.4, 'threshold': 20} |
Graph
Absolute values for 0001069308, Acer Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 7,233,988 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,029,236 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 1,067,860 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 9,056,959 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -91,623,828 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 8,263,224 |
| 1 | Liabilities | 1,067,860 |
| 2 | Expenses | 9,056,959 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 7,195,364 |
| 5 | NetIncome | -100,680,787 |
| 6 | ComprehensiveNetIncome | -100,680,787 |
| 7 | BaseVar | 55,005,936 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -18.2 |
| 9 | EconomicCapitalRatio | 0.00000000000416 |
Edgar->Model Mapping
Feature Distribution
